Photo Rounds

Growths on eyelids

A 53-year-old woman asked her family physician (FP) to examine the growths on her eyelids that had developed over the previous year. The growths were not painful, nor did they itch. A year earlier, the patient had been diagnosed with hyperlipidemia, but she admitted that she didn’t like taking her medication. The remainder of her exam was normal, other than her borderline high blood pressure.

What's your diagnosis?


 

The FP recognized the yellow papules on the patient’s eyelids as xanthelasma (xanthoma palpebrarum). Xanthelasma is most often seen on the medial aspect of the eyelids; the upper lids are more often affected than are the lower lids. Fifty percent of patients with xanthelasmas have normal lipid profiles.

Xanthelasma lesions may be treated for cosmetic purposes. Methods include surgery, electrosurgery, cryotherapy, and laser therapy.

In this case, the FP counseled the patient to take her lipid-lowering medication, explaining that her xanthelasma was a visible sign of her elevated cholesterol. The patient didn’t want to pursue cosmetic treatment for the xanthelasma, but said she’d be willing to take her lipid-lowering medication regularly. The physician also told her he wanted to have her fasting lipid profile measured in a month.

Photos and text for Photo Rounds Friday courtesy of Richard P. Usatine, MD. This case was adapted from: Smith M. Xanthomas. In: Usatine R, Smith M, Mayeaux EJ, et al, eds. The Color Atlas of Family Medicine. New York, NY: McGraw-Hill; 2009:951-953.

To learn more about The Color Atlas of Family Medicine, see:

• http://www.amazon.com/Color-Atlas-Family-Medicine/dp/0071474641

You can now get The Color Atlas of Family Medicine as an app for mobile devices including the iPhone, iPad, and all Android devices by clicking this link:

• http://usatinemedia.com/

Recommended Reading

Bariatric surgery cut vascular events in diabetes
MDedge Family Medicine
FDA approves abiraterone use ahead of prostate cancer chemotherapy
MDedge Family Medicine
Liver function monitoring for methotrexate needs more study
MDedge Family Medicine
Chronic hepatitis C: new cause for optimism
MDedge Family Medicine
Beta-blockers had no impact on CKD mortality
MDedge Family Medicine
HERA: Trastuzumab survival benefit strong at 8 years
MDedge Family Medicine
Coffee, caffeine, and glucose tolerance
MDedge Family Medicine
Ribavirin dose reduction, erythropoietin combat HCV anemia
MDedge Family Medicine
Interferon plus entecavir may tame chronic HBV
MDedge Family Medicine
ED syncope observation protocol safely saves money
MDedge Family Medicine